A recent Phase 3 clinical trial highlighted a new bispecific antibody, etentamig, as a promising treatment for patients with triple-class–exposed multiple myeloma. The drug significantly improved the

The FDA has approved lirafugratinib (Lyrfigtu), a new targeted therapy for patients with advanced cholangiocarcinoma, also known as bile duct cancer, that carries specific FGFR2 genetic mutations. Thi

Matjaž Trontelj, novi predsednik sveta UKC Ljubljana, je tudi zastopnik lobističnega združenja, ki se bori za interese zasebnih klinik. Kako gre to skupaj? In kaj o tem pravi sam?

Insilico Medicine's AI-developed drug, rentosertib, originally designed to treat idiopathic pulmonary fibrosis (IPF), has demonstrated an unexpected effect: it appears to reduce biological age in pati

OS Therapies announced positive interim 3-year overall survival data for its OST-HER2 immunotherapy in a Phase 2b clinical trial for pulmonary metastatic osteosarcoma, a rare and aggressive bone cance

A planned elevation of Timothy D Price, III, the senior pastor of First Baptist Church City of St Louis in Missouri, to the role of Missouri State Overseer in the Full Gospel Baptist Church

Researchers have developed AdaptiveFlow, an AI-powered platform that drastically reduces the computational cost and time required for virtual drug screenings. This new open-source platform, published